Prebiotic supplementation may serve as an inexpensive and low-risk treatment addition to improve glycemic control in patients with type 1 diabetes.
If approved, it would be the first room temperature stable liquid glucagon in an autoinjector formulation.
Completion of full rotavirus vaccination appears to be associated with a reduction in the risk of type 1 diabetes in children.
Both pediatric and adult patients with type 1 diabetes had favorable outcomes for glycemic control with use of the Omnipod® Insulin Management System.
Dasiglucagon was found to be an effective and safe treatment option for severe hypoglycemia in type 1 diabetes.
Patients who attended complication screenings paid more visits to diabetes clinics within the first 2 years after diagnosis, had higher median lifetime HbA1c, and had less socioeconomic disadvantage.
Closed-loop insulin delivery may mitigate potential changes in glycemic control throughout the menstrual cycle.
In people at high risk of developing type 1 diabetes (T1D), teplizumab may delay or prevent disease progression.
The Omnipod HCL system was safe and performed well in children aged 2 to 6 years with type 1 diabetes.
A gluten-free diet was associated with lower insulin demand and HbA1c in T1D.
When screening for depression in adolescents with type 1 diabetes, the PHQ-9 had a higher sensitivity compared with the PROMIS questionnaire.
Researchers reported that collaboration among medical providers, patients, and caregivers was important for optimal glycemic control in youth with type 1 diabetes.
Researchers sent adults with type 1 diabetes a quantitative survey in order to better understand unmet needs and patient preferences.
Type 1 diabetes diagnosed in those older than age 30 years is clinically and biologically similar to disease occurring at younger ages but is often misidentified.
For children with type 1 diabetes, adverse effects on bone mineral density begin early in the course of disease.
Researchers conducted a prospective study focusing on asymptomatic patients with diabetes to investigate the prevalence and prognostic significance of unrecognized MI.
Structured support for patients transitioning from pediatric to adult care for type 1 diabetes may improve outcomes, but those benefits are not sustained after completion of the intervention.
Metabolic syndrome has traditionally been described as having 3 or more cardiovascular risk factors such as altered glucose metabolism, hypertension, abdominal obesity, and dyslipidemia.
Benefits observed without increase in time spent in hypoglycemic range
Individuals who tend to experience negative affect and diabetes distress before eating are at increased risk for objective binge eating at an upcoming meal.